CoChat

Cdk5 Protein Inhibition and Aβ42 Increase BACE1 Protein Level in Primary Neurons by a Post-transcriptional Mechanism

Sadleir, Katherine R., Vassar, Robert · 2012 · Journal of Biological Chemistry
Cited by 52

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m111.333914

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 25 references

Research works printed but not linked: 39

  1. Vassar, 1999, β-Secretase cleavage of Alzheimer amyloid precursor protein by the transmembrane aspartic protease BACE, Science, 286, 735, 10.1126/science.286.5440.735 · DOI · Paper page
  2. Cai, 2001, BACE1 is the major β-secretase for generation of Aβ peptides by neurons, Nat. Neurosci., 4, 233, 10.1038/85064 · DOI · Paper page
  3. Kao, 2004, BACE1 suppression by RNA interference in primary cortical neurons, J. Biol. Chem., 279, 1942, 10.1074/jbc.M309219200 · DOI · Paper page
  4. Singer, 2005, Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model, Nat. Neurosci., 8, 1343, 10.1038/nn1531 · DOI · Paper page
  5. Bodendorf, 2002, Expression of human β-secretase in the mouse brain increases the steady-state level of β-amyloid, J. Neurochem., 80, 799, 10.1046/j.0022-3042.2002.00770.x · DOI · Paper page
  6. Chiocco, 2004, Altered amyloid-β metabolism and deposition in genomic-based β-secretase transgenic mice, J. Biol. Chem., 279, 52535, 10.1074/jbc.M409680200 · DOI · Paper page
  7. Mohajeri, 2004, Transgenic BACE expression in mouse neurons accelerates amyloid plaque pathology, J. Neural Transm., 111, 413, 10.1007/s00702-003-0057-z · DOI
  8. Fukumoto, 2002, β-Secretase protein and activity are increased in the neocortex in Alzheimer disease, Arch. Neurol., 59, 1381, 10.1001/archneur.59.9.1381 · DOI · Paper page
  9. Li, 2004, Amyloid β peptide load is correlated with increased β-secretase activity in sporadic Alzheimer disease patients, Proc. Natl. Acad. Sci. U.S.A., 101, 3632, 10.1073/pnas.0205689101 · DOI · Paper page
  10. O'Connor, 2008, Phosphorylation of the translation initiation factor eIF2α increases BACE1 levels and promotes amyloidogenesis, Neuron, 60, 988, 10.1016/j.neuron.2008.10.047 · DOI · Paper page
  11. Dominguez, 2005, Phenotypic and biochemical analyses of BACE1- and BACE2-deficient mice, J. Biol. Chem., 280, 30797, 10.1074/jbc.M505249200 · DOI · Paper page
  12. Ohno, 2006, Temporal memory deficits in Alzheimer mouse models. Rescue by genetic deletion of BACE1, Eur. J. Neurosci., 23, 251, 10.1111/j.1460-9568.2005.04551.x · DOI · Paper page
  13. Ohno, 2004, BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer disease, Neuron, 41, 27, 10.1016/S0896-6273(03)00810-9 · DOI · Paper page
  14. Zhang, 2009, β-Secretase-1 elevation in transgenic mouse models of Alzheimer disease is associated with synaptic/axonal pathology and amyloidogenesis. Implications for neuritic plaque development, Eur. J. Neurosci., 30, 2271, 10.1111/j.1460-9568.2009.07017.x · DOI · Paper page
  15. Lee, 2000, Neurotoxicity induces cleavage of p35 to p25 by calpain, Nature, 405, 360, 10.1038/35012636 · DOI · Paper page
  16. Patrick, 1999, Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration, Nature, 402, 615, 10.1038/45159 · DOI · Paper page
  17. Cruz, 2006, p25/cyclin-dependent kinase 5 induces production and intraneuronal accumulation of amyloid β in vivo, J. Neurosci., 26, 10536, 10.1523/JNEUROSCI.3133-06.2006 · DOI · Paper page
  18. Wen, 2008, Transcriptional regulation of β-secretase by p25/cdk5 leads to enhanced amyloidogenic processing, Neuron, 57, 680, 10.1016/j.neuron.2008.02.024 · DOI · Paper page
  19. Louneva, 2008, Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer disease, Am. J. Pathol., 173, 1488, 10.2353/ajpath.2008.080434 · DOI · Paper page
  20. Selznick, 1999, In situ immunodetection of neuronal caspase-3 activation in Alzheimer disease, J. Neuropathol. Exp. Neurol., 58, 1020, 10.1097/00005072-199909000-00012 · DOI · Paper page
  21. Stadelmann, 1999, Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer disease. Evidence for apoptotic cell death, Am. J. Pathol., 155, 1459, 10.1016/S0002-9440(10)65460-0 · DOI · Paper page
  22. Su, 2001, Activated caspase-3 expression in Alzheimer and aged control brain. Correlation with Alzheimer pathology, Brain Res., 898, 350, 10.1016/S0006-8993(01)02018-2 · DOI · Paper page
  23. Borghi, 2002, Increase of cdk5 is related to neurofibrillary pathology in progressive supranuclear palsy, Neurology, 58, 589, 10.1212/WNL.58.4.589 · DOI · Paper page
  24. Nguyen, 2002, Controversies over p25 in Alzheimer disease, J. Alzheimer's Dis., 4, 123, 10.3233/JAD-2002-4207 · DOI
  25. Takashima, 2001, Involvement of cyclin-dependent kinase5 activator p25 on Tau phosphorylation in mouse brain, Neurosci. Lett., 306, 37, 10.1016/S0304-3940(01)01864-X · DOI
  26. Tandon, 2003, Brain levels of CDK5 activator p25 are not increased in Alzheimer or other neurodegenerative diseases with neurofibrillary tangles, J. Neurochem., 86, 572, 10.1046/j.1471-4159.2003.01865.x · DOI · Paper page
  27. Taniguchi, 2001, Calpain-mediated degradation of p35 to p25 in postmortem human and rat brains, FEBS Lett., 489, 46, 10.1016/S0014-5793(00)02431-5 · DOI · Paper page
  28. Yoo, 2001, p25 protein in neurodegeneration, Nature, 411, 763, 10.1038/35081146 · DOI
  29. Bennett, 2005, The Rush Memory and Aging Project. Study design and base-line characteristics of the study cohort, Neuroepidemiology, 25, 163, 10.1159/000087446 · DOI · Paper page
  30. Lesné, 2008, Plaque-bearing mice with reduced levels of oligomeric amyloid-β assemblies have intact memory function, Neuroscience, 151, 745, 10.1016/j.neuroscience.2007.10.054 · DOI
  31. Shankar, 2008, Amyloid-β protein dimers isolated directly from Alzheimer brains impair synaptic plasticity and memory, Nat. Med., 14, 837, 10.1038/nm1782 · DOI · Paper page
  32. Lee, 2003, APP processing is regulated by cytoplasmic phosphorylation, J. Cell Biol., 163, 83, 10.1083/jcb.200301115 · DOI · Paper page
  33. Zheng, 2002, A peptide derived from cyclin-dependent kinase activator (p35) specifically inhibits Cdk5 activity and phosphorylation of Tau protein in transfected cells, Eur. J. Biochem., 269, 4427, 10.1046/j.1432-1033.2002.03133.x · DOI · Paper page
  34. Kerokoski, 2001, The levels of cdk5 and p35 proteins and Tau phosphorylation are reduced during neuronal apoptosis, Biochem. Biophys. Res. Commun., 280, 998, 10.1006/bbrc.2001.4240 · DOI
  35. Zempel, 2010, Aβ oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines, J. Neurosci., 30, 11938, 10.1523/JNEUROSCI.2357-10.2010 · DOI · Paper page
  36. Yamin, 2009, NMDA receptor-dependent signaling pathways that underlie amyloid β-protein disruption of LTP in the hippocampus, J. Neurosci. Res., 87, 1729, 10.1002/jnr.21998 · DOI · Paper page
  37. Mengesdorf, 2002, Down-regulation of Parkin protein in transient focal cerebral ischemia. A link between stroke and degenerative disease?, Proc. Natl. Acad. Sci. U.S.A., 99, 15042, 10.1073/pnas.232588799 · DOI
  38. Sheng, 2003, The β-amyloid-related proteins presenilin 1 and BACE1 are axonally transported to nerve terminals in the brain, Exp. Neurol., 184, 1053, 10.1016/j.expneurol.2003.08.018 · DOI · Paper page
  39. Jacobs, 2006, Cyclin-dependent kinase 5, Munc18a, and Munc18-interacting protein 1/X11α protein up-regulation in Alzheimer disease, Neuroscience, 138, 511, 10.1016/j.neuroscience.2005.11.017 · DOI

Cited by

See all 52

Metadata

Authors
Sadleir, K. R., & Vassar, R.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2012-03
Volume
287
Issue
10
Pages
7224-7235
ISSN
0021-9258
Cited by
52
References
25
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cdk5 Protein Inhibition and Aβ42 Increase BACE1 Protein Level in Primary Neurons by a Post-transcriptional Mechanism. https://app.cochat.ai/papers/10.1074/jbc.m111.333914
The paper
Sadleir, K. R., & Vassar, R. (2012). Cdk5 Protein Inhibition and Aβ42 Increase BACE1 Protein Level in Primary Neurons by a Post-transcriptional Mechanism. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.m111.333914

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.